About Black Diamond Therapeutics
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Key Facts
- Industry
- Finance & Banking
- Founded
- 2017
- Headquarters
- Cambridge, MA
- Company size
- 101-250 employees
- Website
- blackdiamondtherapeutics.com
- Operating status
- Active
- Phone
- 617-417-5868
- Legal Name
- Black Diamond Therapeutics, Inc.
- Company Type
- For Profit
- Last Funding Type
- Post-IPO Equity
- Stock Symbol
- NASDAQ:BDTX
- Last Investment Activity
- Feb 22, 2024
- Investments Activity
- Feb 22, 2024, Oct 15, 2023, Sep 18, 2023
- Phone Number
- 617-417-5868
Email Deliverability
↻ Sign in to regenerateDNS health check for blackdiamondtherapeutics.com
Leadership & Decision Makers
Contact details of 9 Black Diamond Therapeutics decision makers
David M. Epstein
Tai-An Lin
Alexander Mayweg
Christopher Roberts
Sergey Yurasov
Elizabeth Montgomery
Elizabeth Buck
Brent Hatzis-Schoch
Alexander Flohr
General Emails
General company emails, e.g. customer support lines
Similar Companies like Black Diamond Therapeutics
HQ: Tel Aviv-yafo, Tel Aviv, Israel
HQ: Menlo Park, California, United States
HQ: New York, NY
HQ: Toronto, Ontario, Canada
HQ: New York, NY
Frequently Asked Questions about Black Diamond Therapeutics
What does Black Diamond Therapeutics do?
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Where is Black Diamond Therapeutics headquartered?
Black Diamond Therapeutics is headquartered in Cambridge, MA.
When was Black Diamond Therapeutics founded?
Black Diamond Therapeutics was founded in 2017.
How many employees does Black Diamond Therapeutics have?
Black Diamond Therapeutics has approximately 101-250 employees.
What industry is Black Diamond Therapeutics in?
Black Diamond Therapeutics operates in the Finance & Banking industry.
How do I contact Black Diamond Therapeutics?
You can contact Black Diamond Therapeutics via email at info@bdtherapeutics.com, headquartered in Cambridge, MA.